<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter"><?OLF?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Intensive Care Med</journal-id><journal-id journal-id-type="iso-abbrev">Intensive Care Med</journal-id><journal-title-group><journal-title>Intensive Care Medicine</journal-title></journal-title-group><issn pub-type="ppub">0342-4642</issn><issn pub-type="epub">1432-1238</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7175449</article-id><article-id pub-id-type="publisher-id">6040</article-id><article-id pub-id-type="doi">10.1007/s00134-020-06040-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter</subject></subj-group></article-categories><title-group><article-title>Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Tavazzi</surname><given-names>Guido</given-names></name><address><email>guido.tavazzi@unipv.it</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Civardi</surname><given-names>Luca</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Caneva</surname><given-names>Luca</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mongodi</surname><given-names>Silvia</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mojoli</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.8982.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1762 5736</institution-id><institution>Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, Unit of Anaesthesia and Intensive Care, </institution><institution>University of Pavia, </institution></institution-wrap>Pavia, Italy </aff><aff id="Aff2"><label>2</label>Anesthesia and Intensive Care, Fondazione Policlinico San Matteo Hospital IRCCS, Pavia, Italy </aff></contrib-group><pub-date pub-type="epub"><day>22</day><month>4</month><year>2020</year></pub-date><fpage>1</fpage><lpage>3</lpage><history><date date-type="accepted"><day>4</day><month>4</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; Springer-Verlag GmbH Germany, part of Springer Nature 2020</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions></article-meta></front><body><p id="Par1">Dear Editor,</p><p id="Par2">The COVID-19 outbreak in Wuhan city, China, in December 2019 has rapidly spread up to the level of Pandemia at the beginning of March 2020. A recent report from China has identified high inflammatory status as a predictor of adverse outcome, suggesting that mortality might be due to virally driven hyper-inflammation status [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par3">There is a well-established link between inflammation and increased risk of deep vein thrombosis (DVT). A potential explanation is that vessel wall inflammation initiates thrombus formation, through the activation of endothelial cells, platelets, and leukocytes that trigger the coagulation pathway [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par4">Additionally, procoagulant state has long been recognized also as part of ARDS pathophysiology, demonstrated by the identification of diffuse pulmonary endothelial injury associated with platelets' activation, macro- and micro-thrombi thought to be either embolic, formed in situ or both [<xref ref-type="bibr" rid="CR4">4</xref>]. Moreover, the interaction pathway among platelets, neutrophils, and endothelial cells' dysfunction in ARDS has been associated with deep vein thrombosis development [<xref ref-type="bibr" rid="CR2">2</xref>]. High prevalence of acute pulmonary embolism (APE) has been recently reported in patients admitted with COVID-19-related pneumonia [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par5">We report the prevalence of venous thrombotic events in patients consecutively admitted to the ICU of a Hub Hospital for SARS-CoV-2 since the beginning of the Italian outbreak infection on February 21, 2020. Informed consent was collected following the<italic> ad hoc</italic> procedures defined&#x000a0;by&#x000a0;the Ethics Committee for the COVID-19 pandemic.</p><p id="Par6">All patients were sedated, mechanically ventilated and treated with prophylactic low-molecular-weight heparin (LMWH) adjusted on body weight since the admission.</p><p id="Par7">Eight out of 54 patients (14.8%) were diagnosed with deep vein thrombosis, 6 of which were central catheter-related. Additionally, one patient had a thrombotic formation attached to the tricuspid valve in the absence of predisposing factors. Sub-segmental pulmonary embolism was found in two patients examined with computed tomography pulmonary angiography (CTPA) and one patient died of cardiac arrest with pulseless electrical activity (PEA) as presentation rhythm and sudden right ventricular dilatation.</p><p id="Par8">In our experience 22.2% of patients (83% male, 68&#x02009;&#x000b1;&#x02009;7&#x000a0;years old; BMI 29.3&#x02009;&#x000b1;&#x02009;4.4&#x000a0;kg/m<sup>2</sup>; C-reactive protein 25.7&#x02009;&#x000b1;&#x02009;9.2&#x000a0;mg/dl, fibrinogen 657.1&#x02009;&#x000b1;&#x02009;200.6&#x000a0;mg/dl) admitted to ICU due to SARS-CoV-2 interstitial pneumonia had venous thrombotic events (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Ultrasound demonstration of thrombotic events in patients admitted with SARS-Cov2. Deep vein ultrasound showing (<bold>a</bold>&#x02014;ESM1) the internal jugular vein with a thrombus surrounding a central catheter (central white point) and (<bold>b</bold>&#x02014;ESM2) a thrombus of superficial and common femoral vein (white asterisk). Transthoracic echocardiography subcostal view demonstrating (<bold>c</bold>&#x02014;ESM3) a thrombus in the right ventricular cavity, attached to the tricuspid valve (white arrow) and (<bold>d</bold>&#x02014;ESM4) parasternal short axis view in patient with right ventricular dilatation (right ventricular/left ventricular area 0.7) inducing interventricular paradoxical septal motion</p></caption><graphic xlink:href="134_2020_6040_Fig1_HTML" id="MO1"/></fig></p><p id="Par9">ICU admission and ARDS are considered both predisposing factors for a number of reasons, including the need for prolonged immobilization and hyper-inflammatory state. The prevalence of vein thrombosis in patients admitted with ARDS is currently unknown.</p><p id="Par10">A recent report showed that 10 out of 25 patients admitted with pneumonia due to COVID-19 presented sub-segmental APE, assessed with CPTA. No associated deep vein thrombosis was reported as the authors did not perform ultrasound screening.</p><p id="Par11">Because of the pathophysiological link between inflammation and thrombosis development [<xref ref-type="bibr" rid="CR3">3</xref>], especially in critically ill patients, the hyper-inflammatory status of patients with COVID-19 [<xref ref-type="bibr" rid="CR1">1</xref>] and the high prevalence of APE [<xref ref-type="bibr" rid="CR5">5</xref>] and of vein thrombotic events found in our population, we strongly suggest that a close vein ultrasound screening and monitoring should be performed in all patients hospitalized due to SARS-CoV-2-related infection. Additionally, right ventricular dilatation/dysfunction should trigger the suspicion of APE.</p><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec1"><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="134_2020_6040_MOESM1_ESM.mov"><caption><p>Supplementary material 1 (MOV 24576&#x000a0;kb)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="134_2020_6040_MOESM2_ESM.mov"><caption><p>Supplementary material 2 (MOV 19509&#x000a0;kb)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="134_2020_6040_MOESM3_ESM.mov"><caption><p>Supplementary material 3 (MOV 5325&#x000a0;kb)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="134_2020_6040_MOESM4_ESM.mov"><caption><p>Supplementary material 4 (MOV 5320&#x000a0;kb)</p></caption></media></supplementary-material></p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank all the nurses and physicians involved in the management of such epidemics and the Pavia COVID-19 Task Force (Dr. Marena Carlo; Dr. Calvi Monica; Dr Grugnetti Giuseppina; Dr Maurelli Marco; Dr Muzzi Alba; Prof. Raffaele Bruno; Dr Lago Paolo; Prof. Marseglia Gianluigi; Prof. Perlini Stefano; Dr Palo Alessandra; Prof Baldanti Fausto; Prof. Corsico Angelo Guido; Prof. Di Sabatino Antonio, Prof. Iotti Giorgio; Prof. Benazzo Marco, Prof.Carlo Nicora, Prof.Antonio Triarico and Dr. Vincenzo Petronella).</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>All authors contributed to data collection and redaction, writing and final revision before submission of the paper.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>No external funding was used, authors used institutional fundings. The corresponding author had full access to the data and had final responsibility for the decision of submitting for publication.</p></notes><notes notes-type="ethics"><title>Compliance with ethical standards</title><notes notes-type="COI-statement"><title>Conflicts of interest</title><p id="Par12">FM received fees for lectures from GE Healthcare, Hamilton Medical, SEDA SpA, outside the present work. SM received fees for lectures from GE Healthcare, outside the present work. GT received fees for lectures by GE Healthcare, outside the present work.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>J</given-names></name></person-group><article-title>Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China</article-title><source>Intensive Care Med</source><year>2020</year><pub-id pub-id-type="doi">10.1007/s00134-020-05991-x</pub-id><?supplied-pmid 32253449?><pub-id pub-id-type="pmid">32253449</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frantzeskaki</surname><given-names>F</given-names></name><name><surname>Armaganidis</surname><given-names>A</given-names></name><name><surname>Orfanos</surname><given-names>SE</given-names></name></person-group><article-title>Immunothrombosis in acute respiratory distress syndrome: cross talks between inflammation and coagulation</article-title><source>Respiration</source><year>2017</year><volume>93</volume><issue>3</issue><fpage>212</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1159/000453002</pub-id><pub-id pub-id-type="pmid">27997925</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saghazadeh</surname><given-names>A</given-names></name><name><surname>Hafizi</surname><given-names>S</given-names></name><name><surname>Rezaei</surname><given-names>N</given-names></name></person-group><article-title>Inflammation in venous thromboembolism: cause or consequence?</article-title><source>Int Immunopharmacol</source><year>2015</year><volume>28</volume><issue>1</issue><fpage>655</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2015.07.044</pub-id><pub-id pub-id-type="pmid">26253657</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomashefski</surname><given-names>JF</given-names><suffix>Jr</suffix></name><name><surname>Davies</surname><given-names>P</given-names></name><name><surname>Boggis</surname><given-names>C</given-names></name><name><surname>Greene</surname><given-names>R</given-names></name><name><surname>Zapol</surname><given-names>WM</given-names></name><name><surname>Reid</surname><given-names>LM</given-names></name></person-group><article-title>The pulmonary vascular lesions of the adult respiratory distress syndrome</article-title><source>Am J Pathol</source><year>1983</year><volume>112</volume><issue>1</issue><fpage>112</fpage><lpage>126</lpage><?supplied-pmid 6859225?><pub-id pub-id-type="pmid">6859225</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, Fafi-Kremer S, Castelain V, Schneider F, Grunebaum L, Angl&#x000e9;s-Cano E, Sattler L, Mertes P-M, Meziani F, and for the CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis) (2020) High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 10.1007/s00134-020-06062-x</mixed-citation></ref></ref-list></back></article>